4 results match your criteria: "Sahary Hospital[Affiliation]"
Ann Saudi Med
June 2007
Department of Tuberculosis and Chest Diseases, Sahary Hospital, Riyadh, Saudi Arabia.
Background: Resistance to antituberculosis drugs is an important cause of treatment failure. We evaluated the prevalence and pattern of antituberculosis drug resistance in the central region of Saudi Arabia, and reviewed previous reports from Saudi Arabia.
Materials And Methods: We retrospectively examined the records of sputum smear and culture-positive pulmonary tuberculosis patients admitted consecutively from 1998 through 1999 in a main referral hospital in Riyadh, and analyzed drug sensitivity reports.
Saudi Med J
March 2003
Department of Tuberculosis and Chest Diseases, Sahary Hospital, PO Box 7966, Riyadh 11472, Kingdom of Saudi Arabia.
Objective: The aim of this study is to determine whether diabetes mellitus (DM) alters the radiological manifestations of pulmonary tuberculosis (TB).
Methods: A retrospective review of the medical records and skiagrams of 692 consecutive smear positive pulmonary TB patients admitted in the Sahary Chest Hospital, Riyadh, Kingdom of Saudi Arabia, from January 1998 to December 1999, was performed. One hundred and eighty-seven (27%) patients had an associated DM.
Int J Tuberc Lung Dis
January 2003
Sahary Hospital, Department of Tuberculosis and Chest Diseases, Riyadh, Saudi Arabia.
Setting: Studies have shown that adverse outcomes are more likely in patients showing persistent sputum positivity at the end of 2 months of anti-tuberculosis treatment.
Objective: To identify simple clinical, microbiological or radiological factors associated with persistent sputum positivity under national programme conditions.
Design: Sputum smear-positive pulmonary tuberculosis patients admitted in 2 consecutive years to a referral hospital, and who received standard short-course chemotherapy under direct observation, were reviewed retrospectively.
Int J Tuberc Lung Dis
July 2002
Department of Tuberculosis and Chest Diseases, Sahary Hospital, Riyadh, Kingdom of Saudi Arabia.
Objective: To determine the influence of anti-tuberculosis drug resistance existing prior to treatment on the outcome of pulmonary tuberculosis patients receiving standard short-course chemotherapy (SCC) under direct observation under national programme guidelines.
Design: Treatment outcomes of sputum smear- and culture-positive pulmonary tuberculosis patients admitted consecutively from 1998 through 1999 in a referral hospital in Riyadh, Saudi Arabia, were reviewed retrospectively.
Results: A total of 515 patients were reviewed; 139 patients were deported or transferred out.